Home > Publications database > Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions > print

001     277348
005     20240522100547.0
024 7 _ |a 10.1080/19466315.2023.2211023
|2 doi
037 _ _ |a DKFZ-2023-01354
082 _ _ |a 610
100 1 _ |a Calderazzo, Silvia
|0 P:(DE-He78)b5d9469407737829d5348adb615655c6
|b 0
|e First author
|u dkfz
245 _ _ |a Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
260 _ _ |a Alexandria, Va.
|c 2024
|b ASA
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1716365064_7220
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C060#
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Tarima, Sergey
|b 1
700 1 _ |a Reid, Carissa
|0 P:(DE-He78)a06ba45fcf672f893e3d0946fe3f3483
|b 2
|u dkfz
700 1 _ |a Flournoy, Nancy
|0 0000-0003-1299-9299
|b 3
700 1 _ |a Friede, Tim
|0 0000-0001-5347-7441
|b 4
700 1 _ |a Geller, Nancy
|b 5
700 1 _ |a Rosenberger, James L
|b 6
700 1 _ |a Stallard, Nigel
|b 7
700 1 _ |a Ursino, Moreno
|0 0000-0002-5709-4322
|b 8
700 1 _ |a Vandemeulebroecke, Marc
|b 9
700 1 _ |a Van Lancker, Kelly
|0 0000-0003-3458-3788
|b 10
700 1 _ |a Zohar, Sarah
|0 0000-0002-8429-2340
|b 11
773 _ _ |a 10.1080/19466315.2023.2211023
|g p. 1 - 17
|0 PERI:(DE-600)2480040-5
|n 2
|p 141-157
|t Statistics in biopharmaceutical research
|v 16
|y 2024
|x 1946-6315
909 C O |p VDB
|o oai:inrepo02.dkfz.de:277348
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b5d9469407737829d5348adb615655c6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)a06ba45fcf672f893e3d0946fe3f3483
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 0000-0003-3458-3788
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-08
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-08
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b STAT BIOPHARM RES : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-25
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
920 0 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21